Warnings about exaggerated technology claims are resurfacing in the AI market after Tyler Shultz, known for exposing problems at Theranos, said the current AI boom creates strong incentives for companies to mislead customers and investors. The comments, reported by TechCrunch, point to a practical issue for businesses: not every AI product will match its marketing promises, even as adoption pressure increases.

What happened

According to TechCrunch, Shultz argued that the current AI investment cycle creates “a great opportunity to go deceive people”. The comparison draws on the Theranos case, which became a well-known example of a company making claims about technology that did not hold up under scrutiny.

The report links that warning to today’s AI market, where companies are attracting major investment and public attention, often before long-term commercial performance is proven. The source does not suggest that specific AI vendors are acting fraudulently, but it does underline a broader risk: in a fast-moving market, commercial claims may run ahead of technical reality.

Why it matters for European businesses

For European SMEs and larger digital teams, the main issue is operational rather than financial speculation. Many companies are now evaluating generative AI, LLM-based assistants, AI search tools, automation platforms and agent-style systems for customer support, content production, internal knowledge access and workflow automation.

In that environment, overstated vendor claims can create several business risks:

• Procurement risk: businesses may buy tools that do not perform as expected in real workflows.
• Compliance risk: AI systems marketed as “safe”, “compliant” or “fully automated” may still require legal, privacy or human oversight review.
• Security risk: some tools may be introduced without sufficient scrutiny of data handling, access controls or model behaviour.
• Marketing risk: teams may rely on AI outputs for SEO, content or customer communication without adequate quality control.
• Strategic risk: leadership may allocate budget based on vendor promises rather than measurable business outcomes.

This is especially relevant in Europe, where businesses are increasingly balancing AI adoption with governance expectations, data protection obligations and sector-specific accountability requirements. Even where regulation does not prohibit a tool, companies still need evidence that it works as advertised and can be deployed responsibly.

Who may be affected

The warning is most relevant for organisations currently buying, testing or integrating AI systems into business operations, including:

• SMEs adopting AI copilots, chatbots or internal assistants
• Marketing teams using AI for content generation, campaign support or SEO workflows
• E-commerce businesses deploying AI for product content, customer service or merchandising
• IT and digital teams integrating third-party AI APIs, SaaS platforms or workflow automation tools
• Founders and business owners making early-stage AI investment decisions without deep technical evaluation capacity

Regulated businesses may face additional exposure if they rely on supplier claims in areas such as data processing, auditability, security or decision support.

What companies should consider

European businesses do not need to avoid AI adoption because of market hype, but they should approach vendor selection and rollout with stronger controls.

• Request evidence, not just demos: ask vendors for real deployment examples, documented limitations and measurable performance data relevant to your use case.
• Run controlled pilots: test AI tools on limited workflows before wider rollout, with clear success criteria and human review.
• Review data handling: confirm where data is processed, what is retained and how access is controlled.
• Check integration risks: assess whether the tool introduces security, reliability or dependency concerns in existing systems.
• Document human oversight: for customer-facing or operationally important use cases, define who validates outputs and how exceptions are handled.
• Avoid ROI assumptions based on hype: evaluate whether a system reduces cost, saves time or improves quality in practice.

The broader lesson is familiar from earlier technology cycles: rapid market excitement can make it harder to distinguish mature, usable products from ambitious claims. For businesses adopting AI in Europe, disciplined evaluation may be more valuable than moving first.